New drug for chronic hives that don't respond to allergy pills
Part of Immune system & allergy, Skin clinical trials.
This study tests an investigational medication called lesigercept for people with chronic hives that don't get better with standard allergy pills. The goal is to see if it can reduce itching and hives better than placebo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had hives (itchy welts) almost daily for at least 6 months.
- You are still getting hives and itching despite taking a daily allergy pill (like Zyrtec or Claritin).
- You have been taking the same dose of your allergy pill every day for at least the past week.
- You are between 18 and 75 years old.
- You do not have another skin condition (like eczema) that could affect the hives assessment.
- You do not have a serious medical condition (like heart disease, untreated infections, or cancer in the last 5 years).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new oral medication (TLL-018) for people with chronic spontaneous urticaria (hives that last more than 6 weeks) who still have symptoms despite taking antihistamines. The goal is to see if the drug can reduce itching and hives better than placebo.
This study tests whether a new drug called MG-K10 can help people with chronic hives (itchy welts) that haven't improved with standard allergy medications. MG-K10 works differently than regular allergy pills, targeting a specific immune pathway that causes hives.
This trial tests a new medication called THB335 for people with chronic spontaneous urticaria (CSU), which causes hives and itching for months without a clear cause. The study will see if the drug can reduce hives and itching better than a placebo (a pill with no active medicine).
This study tests a new drug, TLL-018, for people with moderate-to-severe chronic hives (CSU) that don't respond well to standard antihistamines. The goal is to see if it works quickly to reduce itching and hives.
This study tests whether a bacterial lysate medicine (OM-85) combined with allergy medication can better control chronic hives in people whose regular allergy pills aren't working well enough. You'll be observed over time to see if this combination is safe and effective.
This trial tests a new injection (CM512) for people with chronic spontaneous urticaria, also known as chronic hives. If you have had itchy hives for at least 6 weeks despite taking regular antihistamines, this study may help find a new treatment option.
Hear when a new Allergic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.